Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.
Fast PCR and Fast Real-Time PCR Instruments

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Science 8 October 1999:
Vol. 286. no. 5438, pp. 216 - 217
DOI: 10.1126/science.286.5438.216
Prev | Table of Contents | Next

News Focus

PROFILE:
Biomedical Heavyweights

Jon Cohen

The Howard Hughes Medical Institute (HHMI) and the U.K.'s Wellcome Trust are the undisputed heavyweights of private biomedical funding. They spend more on research than do most governments, and their influence is soaring along with their endowments. Their differences are as striking as their similarities, however. Wellcome, for example, outspends the U.K. research councils on biomedical research, and it targets specific diseases (such as malaria) and avoids others (namely, cancer) if they're relatively well funded. Hughes mostly funds established researchers, who become HHMI employees while remaining at their home institutions.

Read the Full Text

ADVERTISEMENT
Click Me!

ADVERTISEMENT
Click Me!

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)